BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, March 29, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
April 3, 2009
View Archived Issues
Novel fentanyl formulations are safe and efficacious in cancer pain
Read More
Novel cancer therapeutic compounds claimed by the State University of New Jersey
Read More
Merck KGaA describes new tyrosine kinase inhibitors for cancer treatment
Read More
Substituted CC-1065 analogues claimed by Syntarga
Read More
AstraZeneca claims novel 2-pyrazinylbenzimidazole derivatives for cancer treatment
Read More
Bivalirudin reduces major bleeding in women undergoing percutaneous coronary intervention
Read More
Intracoronary adenosine has no effect on myocardial perfusion
Read More
Valsartan reduces morbidity and mortality in diabetic patients and prevents new-onset diabetes
Read More
Estradiol-platinum(II) hybrid molecule compares well to cisplatin in breast cancer xenografts
Read More
Sildenafil ameliorates effects of experimental renal ischemia-reperfusion
Read More
Sorafenib effective in renal cell carcinoma patients with and without prior nephrectomy
Read More
Alexion submits Soliris NDA in Japan in paroxysmal nocturnal hemoglobinuria
Read More
FDA places ICA-105665 on partial clinical hold
Read More
Mitsubishi Tanabe obtains research and development rights in Asia for EVP-6124
Read More
Plethora amends license agreement for PSD-502 for premature ejaculation
Read More
Pharmaxis completes first component of phase III trial of Bronchitol in cystic fibrosis
Read More
Bioniche completes recruitment in phase III registration clinical trial of Urocidin in cancer
Read More
Bayer HealthCare and Genzyme sign new strategic agreement
Read More
Compugen reports initial results from CAM model of CGEN-25017 peptide
Read More
Strativa acquires worldwide rights to Nascobal nasal spray from QOL
Read More
BioCancell receives Israeli approval to initiate phase I/IIa clinical trial of BC-819
Read More
Almirall to co-market silodosin with Recordati in Spain
Read More
Elan and Wyeth amend bapineuzumab phase III protocol
Read More
FDA accepts for filing Xanodyne's NDA for menorrhagia treatment
Read More
FDA Advisory Committee finds Onglyza cardiovascular risk profile acceptable
Read More